SCOPE 2018

Parexel teams with BioFortis to offer biological sample lifecycle management services

By Melissa Fassbender contact

- Last updated on GMT

(Imag: Getty/angelp)
(Imag: Getty/angelp)

Related tags: Evolution

Parexel has launched a new offering that enables customers to manage patient biological sample assets across the supply chain, as precision medicine becomes more prominent, says VP.

Parexel and BioFortis, a Washington DC Metro area-based company that provides precision medicine technology solutions, announced the new service this week during the 9th Annual SCOPE Summit for Clinical Ops Executives, which is taking place in Orlando, FL.

Precision medicine is becoming more prominent and, with it, there is an increased use of human biological samples, which is expected to continually rise​,” said Sanjay Vyas, corporate vice president and global head, Clinical Trial Supplies and Logistics, Parexel.

Additionally with the changing regulatory landscape, biopharmaceutical companies must now have full visibility into the chain of custody and consent status of human samples throughout the entire lifecycle​,” Vyas told us.

The Biological Sample Lifecycle Management offering combines Parexel’s laboratory logistics and genomic medicine know-how with BioFortis’ web-based consent and sample tracking software, Labmatrix, according to the company.

The new offering will enable companies to meet the requirements of evolving regulations and guidelines, said Vyas.

Additionally, it will “quickly and seamlessly determine details such as what specific research the patient’s sample can be used for, if and how long it will be stored after the study and if it’s to be used for a purpose other than the current research​,” he explained

Related news

Show more

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us


View more